Oliver Townend (GBR), the best eventer in FEI Eventing Ranking, will participate in Equestrian Festival Baborówko. For the total prize money of 100 000 EUR will also compete such great athletes as among others Maxime Livio (FRA), Andreas Dibowski (GER) and Sara Algotsson Osstholt (SWE).
Oliver Townend is a top British eventer, which has represented Great Britain during international 3* and 4* competitions. The athlete is a three-times team medallist at European Eventing Championships (Strzegom 2017, Fontainebleau 2009, Pratoni del Vivaro 2007). Only this year he has participated in competitions on the highest international level – 4* – two times. In May he competed in the Badminton Horse Trials with two horses, where he was placed as 2nd and 5th, and his last success was winning the CCI4* competition during the Land Rover Kentucky Three-Day Event in the United States, where he also competed with two horses. He took home first place aboard Cooley Master Class. In 2017 Oliver Townend has won the CCI4* competition in Burghley and has been placed in the first ten at numerous three-star events.
Oliver Townend will bring two horses to Baborówko, Cillnabradden Evo and Dunbeau, with which he will compete in the hardest class of the event – CIC3*.
“It is a great honour for us to host best athletes in the world in Baborówko,” said Henryk Święcicki jr, the director of the show. “We are sure that it will bring great sport emotions to the audience as well as to the athletes.”
Equestrian Festival Baborówko 2018 will be held in a classic format: on Thursday and Friday the riders will compete in dressage, on Saturday, cross country, and on Sunday, showjumping. All prize-giving ceremonies will be held on Sunday.
Athletes from 15 countries will compete in Baborówko and also we will have the pleasure to see 250 horses. Equestrian Festival Baborówko 2018 will be held from 24th to 27th of May in Baborówko (Poland). The competitors will compete for the total prize money of 100 000 EUR in four international competitions: CIC3*, CIC2*, CIC1*, CICYH1*.